Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,502 | 6 | 65.5% |
| Food and Beverage | $1,140 | 37 | 29.8% |
| Education | $176.79 | 3 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Peripheral Vascular, Inc. | $1,659 | 8 | $0 (2018) |
| Fresenius USA Marketing, Inc. | $1,322 | 3 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $234.07 | 7 | $0 (2022) |
| Mallinckrodt LLC | $123.34 | 1 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $97.70 | 6 | $0 (2023) |
| Keryx Biopharmaceuticals, Inc. | $74.14 | 1 | $0 (2017) |
| Amgen Inc. | $35.91 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $31.53 | 2 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $29.43 | 2 | $0 (2022) |
| AKEBIA THERAPEUTICS INC | $29.18 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $29.52 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($14.92) |
| 2022 | $194.27 | 12 | Bayer HealthCare Pharmaceuticals Inc. ($82.78) |
| 2020 | $152.73 | 5 | Otsuka America Pharmaceutical, Inc. ($109.42) |
| 2019 | $217.67 | 11 | Otsuka America Pharmaceutical, Inc. ($75.64) |
| 2018 | $1,705 | 11 | Bard Peripheral Vascular, Inc. ($1,659) |
| 2017 | $1,519 | 5 | Fresenius USA Marketing, Inc. ($1,322) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardio-renal | ||||||
| 11/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardio-renal | ||||||
| 08/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardio-renal | ||||||
| 07/12/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardio-renal | ||||||
| 06/01/2022 | Amgen Inc. | Tavneos (Drug) | Education | In-kind items and services | $20.08 | General |
| Category: Not Applicable | ||||||
| 06/01/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Not Applicable | ||||||
| 05/25/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Genetic Disease | ||||||
| 05/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Cardio-renal | ||||||
| 05/10/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEPHROLOGY | ||||||
| 04/05/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardio-renal | ||||||
| 02/26/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular | ||||||
| 02/24/2020 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $95.51 | General |
| Category: NEPHROLOGY | ||||||
| 02/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: NEPHROLOGY | ||||||
| 01/22/2020 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEPHROLOGY | ||||||
| 11/14/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEPHROLOGY | ||||||
| 11/05/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Hyperkalemia | ||||||
| 10/10/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 09/17/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Immunology | ||||||
| 09/11/2019 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Respiratory | ||||||
| 09/04/2019 | Outset Medical Inc | — | Food and Beverage | Cash or cash equivalent | $15.52 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 597 | 907 | $172,790 | $83,783 |
| 2022 | 9 | 591 | 1,011 | $246,068 | $98,597 |
| 2021 | 11 | 618 | 1,083 | $268,711 | $113,528 |
| 2020 | 12 | 715 | 1,260 | $265,430 | $118,483 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 244 | $39,040 | $22,684 | 58.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 155 | 196 | $43,968 | $19,407 | 44.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 27 | 72 | $29,160 | $12,038 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 102 | $17,850 | $9,049 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 123 | $15,375 | $7,741 | 50.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 107 | $12,305 | $6,607 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $9,450 | $3,885 | 41.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $4,522 | $1,765 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,120 | $606.34 | 54.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 41 | 160 | $64,800 | $27,804 | 42.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 109 | 285 | $45,600 | $23,012 | 50.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 137 | 158 | $35,208 | $16,431 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 132 | $16,684 | $8,639 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 83 | $13,679 | $7,447 | 54.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 117 | $13,455 | $6,522 | 48.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $8,415 | $4,120 | 49.0% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2022 | 21 | 28 | $43,400 | $2,325 | 5.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 15 | $4,827 | $2,297 | 47.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 57 | 267 | $108,135 | $46,666 | 43.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 104 | 242 | $38,720 | $19,603 | 50.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 108 | 121 | $25,410 | $12,794 | 50.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 123 | 187 | $19,822 | $11,674 | 58.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 60 | $9,420 | $5,679 | 60.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 93 | $10,695 | $5,237 | 49.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $8,228 | $3,968 | 48.2% |
About Dr. Aaron Young, DO
Dr. Aaron Young, DO is a Internal Medicine healthcare provider based in Ashland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2011. The National Provider Identifier (NPI) number assigned to this provider is 1740574219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Young, DO has received a total of $3,818 in payments from pharmaceutical and medical device companies, with $29.52 received in 2023. These payments were reported across 46 transactions from 21 companies. The most common payment nature is "Travel and Lodging" ($2,502).
As a Medicare-enrolled provider, Young has provided services to 2,521 Medicare beneficiaries, totaling 4,261 services with total Medicare billing of $414,390. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Critical Care Medicine
- Location Ashland, OH
- Active Since 06/02/2011
- Last Updated 11/24/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740574219
Products in Payments
- Not Product Related (Medical Supply) $1,322
- FLAIR (Device) $863.61
- FLUENCY (Device) $416.26
- CROSSER (Device) $379.60
- ACTHAR (Biological) $152.77
- JYNARQUE (Drug) $138.52
- Kerendia (Drug) $97.70
- SAMSCA (Drug) $95.55
- Auryxia (Drug) $74.14
- Tavneos (Drug) $35.91
- FARXIGA (Drug) $31.53
- AURYXIA (Drug) $29.18
- BEXSERO (Biological) $26.40
- Precision Flow (Device) $20.28
- SOLIRIS (Drug) $18.17
- Vascepa (Drug) $18.00
- FABRAZYME (Biological) $17.05
- CFN PLEURX (Device) $15.15
- Veltassa (Drug) $13.91
- PREVNAR - 13 (Biological) $13.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ashland
Dr. Basel Edris, Md, MD
Internal Medicine — Payments: $42,620
Dr. Kenneth Leung, M.d, M.D
Internal Medicine — Payments: $10,085
Dr. Mehrdad Tavallaee, Md, MD
Internal Medicine — Payments: $6,878
Diane Settles, Md, MD
Internal Medicine — Payments: $6,278
Alexandr Karimov, M.d, M.D
Internal Medicine — Payments: $5,982
Roger Klein, M.d, M.D
Internal Medicine — Payments: $5,835